| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Annals of Surgical Oncology, Vol 6, Issue 7 633-639, Copyright © 1999 by Society of Surgical Oncology
ARTICLES |
P. I. Haigh, R. Essner, J. C. Wardlaw, S. L. Stern and D. L. Morton
Roy E. Coats Research Laboratories and the Division of Surgical Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California 90404, USA.
BACKGROUND: Survival of patients with American Joint Committee on Cancer stage IV melanoma is generally poor, although there are occasional long-term survivors who have undergone surgical resection of a limited number of metastases. In the study, we examined the outcome of patients with adrenal gland metastases. METHODS: Eighty-three patients with adrenal metastases were identified from our computerized melanoma database of 8250 patients. Univariate and multivariate analyses for overall survival differences were performed by using proportional hazards modeling. RESULTS: Median survival for the 83 patients was 9.3 months (1-67 months). Of the 27 patients who underwent surgical exploration, 18 (66%) were rendered clinically free of disease by adrenalectomy alone (12 cases) or by adrenalectomy and resection of additional disease (6 cases). Nine patients underwent palliative adrenal resection. Median survival was 25.7 months after complete resection compared with 9.2 months after palliative resection (P = .02). CONCLUSIONS: Patients with adrenal metastases from melanoma, either isolated or with a limited number of additional metastases, may benefit from surgical resection if all visible disease can be removed. Patients with unresectable extra-adrenal disease achieve no survival benefit from adrenalectomy.
This article has been cited by other articles:
 |
|
 |
|
  F. J. Collinson, T. K. Lam, W. M. J. Bruijn, J. H. W. de Wilt, M. Lamont, J. F. Thompson, and R. F. Kefford Long-term Survival and Occasional Regression of Distant Melanoma Metastases after Adrenal Metastasectomy Ann. Surg. Oncol., June 1, 2008; 15(6): 1741 - 1749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Pawlik, D. Zorzi, E. K. Abdalla, B. M. Clary, J. E. Gershenwald, M. I. Ross, T. A. Aloia, S. A. Curley, L. H. Camacho, L. Capussotti, et al. Hepatic Resection for Metastatic Melanoma: Distinct Patterns of Recurrence and Prognosis for Ocular Versus Cutaneous Disease Ann. Surg. Oncol., May 1, 2006; 13(5): 712 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. S Mackenzie, M. J Ashby, T. Donovan, D. D Voutnis, and M. J Brown Bilateral adrenal masses: phaeochromocytoma or melanoma? J R Soc Med, March 1, 2006; 99(3): 153 - 155. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Essner, J. H. Lee, L. A. Wanek, H. Itakura, and D. L. Morton Contemporary Surgical Treatment of Advanced-Stage Melanoma Arch Surg, September 1, 2004; 139(9): 961 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Allen and D. G. Coit The Surgical Management of Metastatic Melanoma Ann. Surg. Oncol., October 1, 2002; 9(8): 762 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Wood, L. A. DiFronzo, D. M. Rose, P. I. Haigh, S. L. Stern, L. Wanek, R. Essner, and D. L. Morton Does Complete Resection of Melanoma Metastatic to Solid Intra-Abdominal Organs Improve Survival? Ann. Surg. Oncol., September 1, 2001; 8(8): 658 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Rose, R. Essner, T. M. D. Hughes, P. C. Y. Tang, A. Bilchik, L. A. Wanek, J. F. Thompson, and D. L. Morton Surgical Resection for Metastatic Melanoma to the Liver: The John Wayne Cancer Institute and Sydney Melanoma Unit Experience Arch Surg, August 1, 2001; 136(8): 950 - 955. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
